Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Todd Nelson Moves to MP Biomedicals; Thomas Bologna New CEO at Response Genetics

Premium

MP Biomedicals has named Todd Nelson president and CEO, replacing Milan Panic, founder and CEO, who will remain as chairman of the company.

Nelson was most recently CEO of eBioscience, which is in the process of being acquired by Affymetrix.

Prior to eBioscience, Nelson was vice president of global corporate development and strategy at Life Technologies. Before that, he was managing director and head of global life sciences corporate strategy and research at RBC Capital Markets and first vice president of global corporate strategy and economics at Merrill Lynch.

Nelson holds a PhD in molecular pathology from the University of Minnesota and an MBA from the Carlson School of Business.


Response Genetics has appointed Thomas Bologna as CEO and chairman of the board.

Kirk Calhoun, the former chairman, was elected to the newly created position of lead director of the board.

Denise McNairn, who has served as interim CEO since July, will continue to serve as vice president, general counsel, and secretary.

Bologna joins the firm from Orchid Cellmark (now part of Laboratory Corporation of America), where he was president and CEO.

Prior to that he was president, CEO, and a member of the board of Quorex Pharmaceuticals, which was sold to Pfizer; and chairman, president, and CEO of Ostex International, which was sold to Alere.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.